When you offer phenomenal service, an unrivalled pharma portfolio, and take a global yet personal approach with fantastic partners, it’s only a matter of time before you need to expand.

The countdown has officially started!

We have been quietly working behind the scenes on our new state of the art, ultra-modern lab capable of handling even the most highly potent drugs. We’ve already been GMP inspected by the local state authority, and we’re very nearly ready to welcome our first projects.

Spanning over 500m2, the additional site promises the same level of regulatory rules, standard operating procedures and excellent service as our flagship Prague HQ, and with logistics between the two locations already well established there is no doubt that this expansion will provide the extra capacity needed as Quinta continues to grow.

Excited to hear more about this very special new lab and learn where it’s based? Watch this space!

Also, be sure to follow us on LinkedIn for the latest news and greatest announcements in the pharma industry.

Additional News

  • 9 July 2025

    HER-096: A possible breakthrough in Parkinson’s disease treatment

    This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson’s disease.

  • 9 June 2025

    Ensuring Success in Buccal Film Development: The Midazolam Film Case Study

    Fast, Simple, Effective: Unlocking the Potential of Midazolam Films

  • 15 May 2025

    From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.